Pasquale Rescigno1,2,3, Johann S de Bono4,5. 1. Division of Clinical Studies, The Institute of Cancer Research, London, UK. 2. Prostate Targeted Therapy Group, The Royal Marsden Hospital, London, UK. 3. Department of Clinical Medicine and Surgery, Department of Translational Medical Sciences, AOU Federico II, Naples, Italy. 4. Division of Clinical Studies, The Institute of Cancer Research, London, UK. johann.de-bono@icr.ac.uk. 5. Prostate Targeted Therapy Group, The Royal Marsden Hospital, London, UK. johann.de-bono@icr.ac.uk.
Authors: E M Kwan; I A Thangasamy; J Teh; O Alghazo; N J Sathianathen; N Lawrentschuk; A A Azad Journal: World J Urol Date: 2020-01-02 Impact factor: 4.226
Authors: Niall M Corcoran; Anthony T Papenfuss; Christopher M Hovens; Stefano Mangiola; Patrick McCoy; Martin Modrak; Fernando Souza-Fonseca-Guimaraes; Daniel Blashki; Ryan Stuchbery; Simon P Keam; Michael Kerger; Ken Chow; Chayanica Nasa; Melanie Le Page; Natalie Lister; Simon Monard; Justin Peters; Phil Dundee; Scott G Williams; Anthony J Costello; Paul J Neeson; Bhupinder Pal; Nicholas D Huntington Journal: BMC Cancer Date: 2021-07-22 Impact factor: 4.430